# Dextenza in Pterygium Surgery

> **NCT04403516** · PHASE4 · COMPLETED · sponsor: **Michelle Rhee MD** · enrollment: 30 (actual)

## Conditions studied

- Pterygium

## Interventions

- **DRUG:** Dexamethasone Intracanalicular Insert, 0.4mg
- **DRUG:** Prednisolone Acetate 1%

## Key facts

- **NCT ID:** NCT04403516
- **Lead sponsor:** Michelle Rhee MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2021-08-05
- **Final completion:** 2021-08-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04403516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04403516, "Dextenza in Pterygium Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04403516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*